Merck KGaA expects to publish Stimuvax data in Q1 2013
November 15, 2012 at 05:38 AM EST
FRANKFURT, Nov 15 (Reuters) - German drugmaker Merck KGaA expects first late-stage study results on cancer drug Stimuvax to be available in the first quarter of next year, its chief executive said on Thursday.
